
Pulse Biosciences (PLSE) Stock Forecast & Price Target
Pulse Biosciences (PLSE) Analyst Ratings
Bulls say
Pulse Biosciences is expected to have a significant impact on the AF ablation market with their novel and disruptive NPS technology, led by a strong leadership team and strategic initiatives, potentially leading to future acquisitions or partnerships in the EP market. With a projected growth in the global market for AF ablation, PFA technology is positioned to dominate the market, supported by promising results from PLSE's recent clinical trials and ongoing investments in R&D. As they seek FDA approval for their ablation systems, PLSE expands its reach beyond AF ablation and into other medical procedures.
Bears say
Pulse Biosciences is a relatively new company with limited revenue and faces competition from established players in the medical technology market. Therefore, the financial analyst has a negative outlook on Pulse Biosciences's stock.
This aggregate rating is based on analysts' research of Pulse Biosciences and is not a guaranteed prediction by Public.com or investment advice.
Pulse Biosciences (PLSE) Analyst Forecast & Price Prediction
Start investing in Pulse Biosciences (PLSE)
Order type
Buy in
Order amount
Est. shares
0 shares